InvestorPlace - Stock Market News, Stock Advice & Trading Tips Phio Pharma stock is pulling back on Thursday after shares of PHIO underwent a massive rally on…
Phio Pharmaceuticals Corp. (PHIO) shares are spiking more than 38 percent on Wednesday morning trade after the company presented key pre-clinical studies data for it Intasyl compound PH-894 aimed at melanoma cells, as an antitumor cytotoxic agent.